Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Michael Smith is a leading gynaecological oncologist whose research has fundamentally reshaped surgical practice for early-stage cervical cancer. His landmark 2019 study, "Survival of women with early‐stage cervical cancer in the UK treated with minimal access and open surgery," garnered 24 citations and sparked urgent debate within the oncology community. This work, alongside pivotal publications in the *New England Journal of Medicine*, demonstrated that women undergoing minimal access radical hysterectomy experienced significantly worse outcomes compared to those receiving open surgery. By providing compelling evidence of reduced survival rates with laparoscopic and robotic approaches, Dr. Smith’s research has directly influenced clinical guidelines worldwide, prompting many surgeons to reconsider their operative techniques. His contributions have not only advanced the understanding of oncological safety in surgical innovation but have also prioritized patient outcomes over technological convenience. Dr. Smith’s work continues to guide evidence-based decision-making in gynaecological oncology, ensuring that surgical progress does not come at the cost of patient survival.